2-Methyl-1-(2-methylbutan-2-yl)pyrrolidine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 英文名称: 2-Methyl-1-(2-methylbutan-2-yl)pyrrolidine
• 英文别名: 2-methyl-1-(2-methylbutan-2-yl)pyrrolidine
• 化学式: C₁₀H₂₁N
• 分子量: 155.28
• InChiKey: VSYKJSCVPVLJDI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• Anti-infective heterocyclic compounds and uses thereof
  申请人：Bioimics AB

  公开号：US11130741B2

  公开（公告）日：2021-09-28

  The present invention relates to heterocyclic compounds of Formula I useful as anti-infective agents. The present invention further relates to a method of treating an infection by administering such compounds, and to pharmaceutical compositions comprising such compounds.

  本发明涉及可用作抗感染剂的式Ⅰ杂环化合物。本发明还涉及通过施用此类化合物治疗感染的方法，以及包含此类化合物的药物组合物。
• Antibacterial compounds, compositions thereof, and methods using same
  申请人：The Rockefeller University

  公开号：US11339184B2

  公开（公告）日：2022-05-24

  The present disclosure includes novel compounds useful as antimicrobial agents. The present disclosure further includes methods useful. The present disclosure further includes compositions and methods for treating or preventing a bacterial infection. The present disclosure further includes compositions and methods useful for preventing or reducing the growth or proliferation of microorganisms.

  本公开包括可用作抗菌剂的新型化合物。本公开还包括有用的方法。本公开进一步包括用于治疗或预防细菌感染的组合物和方法。本公开内容还包括用于防止或减少微生物生长或增殖的组合物和方法。
• ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF
  申请人：Bioimics AB

  公开号：US20190233384A1

  公开（公告）日：2019-08-01

  The present invention relates to heterocyclic compounds of Formula I useful as anti-infective agents. The present invention further relates to a method of treating an infection by administering such compounds, and to pharmaceutical compositions comprising such compounds.
• ANTIBACTERIAL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS USING SAME
  申请人：The Rockefeller University

  公开号：US20210024562A1

  公开（公告）日：2021-01-28

  The present disclosure includes novel compounds useful as antimicrobial agents. The present disclosure further includes methods useful. The present disclosure further includes compositions and methods for treating or preventing a bacterial infection. The present disclosure further includes compositions and methods useful for preventing or reducing the growth or proliferation of microorganisms.